Stille (Q3 initial take): Continued headwinds but improving outlook
Redeye provides its initial comments on Stille following the Q3 2025 report, which came in below our projections. Despite a solid outlook, we...
86 Views
Stille Q1’22: Strong Quarter, Despite Supply Chain Challenges
Redeye sees a strong Q1’22 report from Stille, where sales in the operating tables segment surprised us positively. With the global healthcare...
85 Views